ENL Shares Enlitic, Inc.
ASX · ASXLast in our picks 2026-09-28 — not in the current list; analysis below is from that screen
AI-enabled healthcare chip/software angle offers speculative upside if adoption accelerates.
Future value: $0.09 (+125.00%) · 6-12 months
Signal breakdown
- ▸High-variance catalyst story with limited proof points.
- ▾Below 50-day MA (-15.75%)
- ▾Near 52-week low (1.4% of range)
- ▸~125% upside to price target
Is ENL a buy right now?
Trend: ENL is trading below the 50-day average (-27.50%), RSI 36 — neutral momentum, with a 3-month return of -51.67%.
Valuation & quality: fundamentals show net margin 0.0%, return on equity -349.1%, revenue growth -10.5% year on year.
Our screen: ACCUMULATE (score 1) — AI-enabled healthcare chip/software angle offers speculative upside if adoption accelerates.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| +28.60% | +11.10% | -20.00% | -37.50% | +0.00% | +0.00% | -20.00% | -25.00% |
Fundamentals
Technical signals
About Enlitic, Inc.
Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images.
Sector: Healthcare · Industry: Health Information Services · United States · Website
Related Semiconductors picks
Browse: all ASX stocks · Semiconductors picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.